Sex differences in oncogenic mutational processes.

Li CH., Prokopec SD., Sun RX., Yousif F., Schmitz N., PCAWG Tumour Subtypes and Clinical Translation None., Boutros PC., PCAWG Consortium None.

Sex differences have been observed in multiple facets of cancer epidemiology, treatment and biology, and in most cancers outside the sex organs. Efforts to link these clinical differences to specific molecular features have focused on somatic mutations within the coding regions of the genome. Here we report a pan-cancer analysis of sex differences in whole genomes of 1983 tumours of 28 subtypes as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium. We both confirm the results of exome studies, and also uncover previously undescribed sex differences. These include sex-biases in coding and non-coding cancer drivers, mutation prevalence and strikingly, in mutational signatures related to underlying mutational processes. These results underline the pervasiveness of molecular sex differences and strengthen the call for increased consideration of sex in molecular cancer research.

DOI

10.1038/s41467-020-17359-2

Type

Journal article

Journal

Nat Commun

Publication Date

28/08/2020

Volume

11

Keywords

Chromosomal Instability, Exome, Female, Genome, Human, Genomic Instability, Humans, Logistic Models, Male, Mutation, Neoplasms, Oncogenes, Open Reading Frames, Sex Characteristics, beta Catenin

Permalink Original publication